doi: 10.1007/s11695-019-03734-6 6 ApovianCM
You cant eat (nausea, vomiting, diarrhea, inhibition of hunger centers of braini)
The STEP trials for semaglutide 2.4 mg (Wegovy) showed: Average weight loss of approximately 15% of body weight over 68 weeks One-third of participants lost 20% or more of body weight Significant reductions in waist circumference, blood pressure, and cardiovascular risk markers The SURMOUNT trials for tirzepatide (Zepbound) showed even more impressive results: Average weight loss of 20-25% at the highest dose (15 mg) over 72 weeks More than half of participants lost 20% or more of body weight Significant improvements in type 2 diabetes markers, blood pressure, and lipid profiles The head-to-head comparison is clear
This method is particularly effective for individuals with absorption issues, such as those with gastrointestinal disorders or older adults with decreased gastric acid production
However, many users find that eating a light, protein-rich meal before their injection and keeping meals lighter for the following 24 to 48 hours reduces nausea and GI discomfort
Proper medication storage directly impacts treatment outcomes, as degraded medication may deliver subtherapeutic doses, potentially leading to inadequate glycemic control or insufficient weight management effects